Back
BioCryst Pharmaceuticals Quote, Financials, Valuation and Earnings
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
33
BCRX
BioCryst Pharmaceuticals
Last Price:
7.78
Seasonality Move:
8.68%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!BioCryst Pharmaceuticals Price Quote
$7.78
BioCryst Pharmaceuticals Key Stats
Sell
33
BioCryst Pharmaceuticals (BCRX)
is a Sell
Day range:
$7.52 - $7.84
52-week range:
$4.03 - $8.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.87
P/B ratio:
0%
Volume:
1.6M
Avg. volume:
2.1M
1-year change:
42.23%
Market cap:
$1.6B
Revenue:
$331.4M
EPS:
$-0.61
How Much Does BioCryst Pharmaceuticals Make?
-
How Much Are BioCryst Pharmaceuticals's Sales Annually?
BCRX Revenues are $331.4M -
How Much Profit Does BioCryst Pharmaceuticals's Make A Year?
BCRX net income is -$226.5M
Is BioCryst Pharmaceuticals Growing As A Company?
-
What Is BioCryst Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.35% -
What Is BioCryst Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
BioCryst Pharmaceuticals Stock Price Performance
-
Did BioCryst Pharmaceuticals Stock Go Up Last Month?
BioCryst Pharmaceuticals share price went up by 8.06% last month -
Did BCRX's Share Price Rise Over The Last Year?
BCRX share price rose by 42.23% over the past 1 year
What Is BioCryst Pharmaceuticals 52-Week High & Low?
-
What Is BioCryst Pharmaceuticals’s 52-Week High Share Price?
BioCryst Pharmaceuticals has traded as high as $8.88 over the past 52 weeks -
What Is BioCryst Pharmaceuticals’s 52-Week Low Share Price?
BioCryst Pharmaceuticals has traded as low as $4.03 over the past 52 weeks
BioCryst Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy BioCryst Pharmaceuticals?
-
How Much Debt Does BioCryst Pharmaceuticals Have?
Total long term debt quarterly is $796.1M -
How Much Cash Does BioCryst Pharmaceuticals Have?
Cash and short term investments quarterly total is $330M -
What Is BioCryst Pharmaceuticals’s Book Value Per Share?
Book value per share is -2.26
Is BioCryst Pharmaceuticals Cash Flow Positive?
-
What Is BCRX Cash Flow From Operations?
Cash flow from operations (TTM) is -$55.7M -
What Is BioCryst Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$4.9M -
What Is BioCryst Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $6.3M
BioCryst Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
BCRX return on invested capital is -34.87% -
What Is BioCryst Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -25.05% -
What Is BCRX Return On Equity?
ROE is a measure of profitability and is 0%
BioCryst Pharmaceuticals Earnings Date & Stock Price
-
What Is BioCryst Pharmaceuticals's Stock Price Today?
A single share of BCRX can be purchased today for 7.78 -
What Is BioCryst Pharmaceuticals’s Stock Symbol?
BioCryst Pharmaceuticals trades on the nasdaq under the ticker symbol: BCRX -
When Is BioCryst Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for BioCryst Pharmaceuticals is scheduled on February 26, 2025 -
When Is BCRX's next ex-dividend date?
BioCryst Pharmaceuticals's next ex-dividend date is November 10, 2024 -
How To Buy BioCryst Pharmaceuticals Stock?
You can buy BioCryst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
BioCryst Pharmaceuticals Competitors
-
Who Are BioCryst Pharmaceuticals's Competitors?
Below is a list of companies who compete with BioCryst Pharmaceuticals or are related in some way:
BioCryst Pharmaceuticals Dividend Yield
-
What Is BCRX Dividend Yield?
BioCryst Pharmaceuticals’s dividend yield currently is 0% -
What Is BioCryst Pharmaceuticals’s Payout Ratio?
BioCryst Pharmaceuticals’s payout ratio is 0% -
When Did BioCryst Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 10, 2024 -
What Is BioCryst Pharmaceuticals’s Dividend Per Share?
BioCryst Pharmaceuticals pays a dividend of $0.00 per share
BioCryst Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -21.74% |
| Revenue: | 34.98% | 2.71% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 14.64 |
| Upside from Last Price: | 88.13% |